AMTB NYSE Week ended 09 Oct 2026

Weekly Investor Report

Amerant Bancorp Inc. · Financial Services · Banks - Regional

Open interactive chart View report data
Latest close 28.77 USD
-2.7% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 11.9% above the Trend Line and sits at 88.5% of its 52-week range. The latest completed week returned -2.7%, after a -1.9% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is neither clearly cheap nor expensive. Options positioning is mixed with 7/100 conviction, while the latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal; earnings are due in 11d.

Setup score 63 out of 100
Latest Close 28.77 USD 9 Oct 2026
1W Return -2.7% latest completed week
4W Return -1.9% short-term follow-through
12W Return 10.2% quarterly tape
Trend Breadth 71.2% 37 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
What is working
  • The trend backdrop is active with a 37-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 8 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -2.7% Latest completed week; four-week move -1.9%. Indicator stack 84/54 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Mixed 7/100 conviction; expected move 0.0%. News sentiment 50/100 20 relevant articles in the latest sentiment read. Event risk 11d Next report is scheduled for 22 Oct 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 11.9% above the Trend Line and sits at 88.5% of its 52-week range. The latest completed week returned -2.7%, after a -1.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug 14 Aug 21 Aug 28 Aug 4 Sep 11 Sep 18 Sep 25 Sep 2 Oct 9 Oct
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9812-week average 0.97

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.98Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers88 reversal markers

No recent accumulation markers. 8 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -1.9% over four weeks, 10.2% over 12 weeks, and 59.9% over one year. The current trend has remained active for 37 consecutive weeks.

Performance by holding period

1W-2.7%
4W-1.9%
12W10.2%
26W21.3%
52W59.9%
Active trend streak37 weeks
Active weeks in one year37
Trend breadth71.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.50Latest activity-pressure read.
Pressure change-58.6%Four-week change in activity pressure.
Leadership13.75Latest relative-leadership reading.
RS change-34.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 02 Oct 2026 Financial statements through 30 Jun 2026 Field coverage 100% Model confidence 99%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength92/100Blend of value, momentum, and quality. Underlying universe rank 9; rank 1 is best.
Value72/100Relative valuation strength. Underlying universe rank 29; rank 1 is best.
Quality77/100Profitability and accounting quality. Underlying universe rank 24; rank 1 is best.
Momentum97/100Medium-term price momentum. Underlying universe rank 4; rank 1 is best.
Growth21/100Revenue and earnings growth. Underlying universe rank 80; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework41/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
18.9x
Price divided by trailing earnings.
Price / sales
2.0x
Market value relative to trailing revenue.
EV / EBITDA
26.2x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
16.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
65.0%
Gross profit retained from each unit of revenue.
Operating margin
12.5%
Operating profit retained from revenue.
Free-cash-flow margin
57.2%
Free cash flow generated from revenue.
Return on invested capital
3.2%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-3.0%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
112.0%
Latest one-year free-cash-flow growth.
Piotroski F-score
8/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
1.2%
Cash dividends relative to market value.
Buyback yield
5.0%
Net share repurchases relative to market value.
Shareholder yield
6.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
11.2x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

AMTB shows mixed options pressure with a 7/100 conviction score, put-call volume ratio of n/a, expected move of n/a, and Sharemaestro trend signal active.

Conviction7/100
Expected move%
Put/call volume
Pressure5
Speculation0
Volatility54
Trend agreement0
Open options detail
Insider activity14 / 6

14 acquisitions and 6 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment50/100

Weighted news tone is neutral across 20 relevant articles.

0 positive · 20 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings11dNext report is scheduled for 22 Oct 2026; event risk rises as the date approaches.
Options expected move%Nearest-chain priced movement where available.
52-week drawdown-5.7%Distance below the 52-week high.
13-week volatility3.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2610 weeks finished lower.
Best week+8.9%Week of 24 Jul.
Worst week-4.4%Week of 15 May.
Latest week-2.7%Week of 9 Oct.

Shape of recent returns

Strong gains3
Modest gains12
Flat weeks1
Modest losses8
Sharp losses2
Recent vol3.0%13-week weekly-return volatility.
Base vol3.2%52-week weekly-return volatility.
Up/down split31/20Count of positive and negative weeks in the 52-week window.
Average skew3.0% / -2.1%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape66/100

Trend, activity pressure, participation, and risk combine to a 66/100 tape read.

 Indicator analysis83/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.

Activity pressure 0.98; 8 reversal markers Factors84/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 11; Small Cap Core rank 30 SVQF41/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 598.0 of 1007 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options24/100

No clear directional balance. Options do not give a clear directional confirmation of the stock trend.

2026-10-09 · Use with limits · Priced move Unavailable Sentiment50/100

Weighted news tone is neutral across 20 relevant articles.

Amerant Bancorp Q3FY26 Results: Earnings call set for Oct 23 after market close Insiders14 / 6

14 acquisitions and 6 disposals in the latest 180-day insider tape.

 Earnings11d

Next report is scheduled for 22 Oct 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
9 Oct 202628.77 USD-2.7%25.71 USD21.50 USD0.5013.751.4MOn
2 Oct 202629.56 USD-0.0%25.44 USD21.43 USD0.8318.871.7MOn
25 Sep 202629.57 USD-0.8%25.16 USD21.35 USD1.0819.421.7MOn
18 Sep 202629.80 USD1.6%24.88 USD21.27 USD1.1822.482.4MOn
11 Sep 202629.32 USD-1.2%24.64 USD21.19 USD1.2020.991.1MOn
4 Sep 202629.68 USD2.9%24.41 USD21.12 USD1.3522.011.5MOn
28 Aug 202628.84 USD0.5%24.19 USD21.04 USD1.3919.111.2MOn
21 Aug 202628.69 USD-1.6%23.94 USD20.98 USD1.5719.371.6MOn
14 Aug 202629.17 USD1.2%23.69 USD20.91 USD1.6720.052.0MOn
7 Aug 202628.82 USD-2.3%23.40 USD20.84 USD1.6619.291.9MOn
31 Jul 202629.51 USD3.9%23.12 USD20.78 USD1.5927.043.1MOn
24 Jul 202628.41 USD8.9%22.79 USD20.71 USD1.5124.412.5MOn
17 Jul 202626.10 USD2.7%22.50 USD20.65 USD1.4914.101.8MOn
10 Jul 202625.42 USD0.2%22.30 USD20.60 USD1.339.661.3MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context